Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (hereinafter, "VHIR")

Barcelona 08035

1 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer

Studies at this site

• This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1. — Recruiting now